Marina Ryzhova
Overview
Explore the profile of Marina Ryzhova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
10014
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pavlova S, Fab L, Savchenko E, Ryabova A, Ryzhova M, Revishchin A, et al.
Pharmaceuticals (Basel)
. 2024 Jan;
17(1).
PMID: 38256907
High-grade gliomas are considered an incurable disease. Despite all the various therapy options available, patient survival remains low, and the tumor usually returns. Tumor resistance to conventional therapy and stimulation...
2.
Morgacheva D, Ryzhova M, Zheludkova O, Belogurova M, Dinikina Y
Front Pediatr
. 2023 Oct;
11:1256876.
PMID: 37818165
Central nervous system (CNS) tumors in children comprise a highly heterogenous and complex group of diseases. Historically, diagnosis and confirmation of these tumors were routinely based on histological examination. However,...
3.
Gorelyshev S, Medvedeva O, Mazerkina N, Ryzhova M, Krotkova O, Golanov A
Adv Exp Med Biol
. 2023 Jul;
1405:117-152.
PMID: 37452937
Medulloblastoma is the primary malignant embryonic tumor of the cerebellum and the most common malignant tumor of childhood, accounting up to 25% of all CNS tumors in children, but is...
4.
Stanishevskiy A, Jakovenko A, Ryzhova M, Svistov D, Gizatullin S, Babichev K, et al.
Surg Neurol Int
. 2022 Nov;
13:531.
PMID: 36447886
Background: Chronic subdural hematomas (cSDHs) are frequent and potentially life-threatening neurosurgical conditions affecting, first of all, elderly. Few treatment options are available ranging from observation to removal thought large craniotomy....
5.
Nasir A, Cardall A, Othman R, Nicolaou N, Lourdusamy A, Linke F, et al.
Neurooncol Adv
. 2022 Jan;
3(1):vdab155.
PMID: 34988447
[This corrects the article DOI: 10.1093/noajnl/vdab030.].
6.
Delaidelli A, Dunham C, Santi M, Negri G, Triscott J, Zheludkova O, et al.
Clin Cancer Res
. 2021 Oct;
28(1):116-128.
PMID: 34702771
Purpose: International consensus and the 2021 WHO classification recognize eight molecular subgroups among non-WNT/non-SHH (Group 3/4) medulloblastoma, representing approximately 60% of tumors. However, very few clinical centers worldwide possess the...
7.
Deng M, Sturm D, Pfaff E, Sill M, Stichel D, Balasubramanian G, et al.
Nat Commun
. 2021 Sep;
12(1):5530.
PMID: 34545083
Long-term complications such as radiation-induced second malignancies occur in a subset of patients following radiation-therapy, particularly relevant in pediatric patients due to the long follow-up period in case of survival....
8.
Coltin H, Sundaresan L, Smith K, Skowron P, Massimi L, Eberhart C, et al.
Acta Neuropathol
. 2021 Aug;
142(5):859-871.
PMID: 34409497
Medulloblastoma, a common pediatric malignant central nervous system tumour, represent a small proportion of brain tumours in adults. Previously it has been shown that in adults, Sonic Hedgehog (SHH)-activated tumours...
9.
Belyaev A, Usachev D, Ryzhova M, Gulida G, Skvortsova V, Pronin I, et al.
J Clin Neurosci
. 2021 Aug;
91:249-254.
PMID: 34373036
Adult cerebellar anaplastic astrocytomas (cAA) are rare entities and their clinical and genetic appearances are still ill defined. Previously, malignant gliomas of the cerebellum were combined and reviewed together (cAA...
10.
von Hoff K, Haberler C, Schmitt-Hoffner F, Schepke E, de Rojas T, Jacobs S, et al.
Neuro Oncol
. 2021 Jun;
23(9):1597-1611.
PMID: 34077956
Background: Only few data are available on treatment-associated behavior of distinct rare CNS embryonal tumor entities previously treated as "CNS-primitive neuroectodermal tumors" (CNS-PNET). Respective data on specific entities, including CNS...